The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAptitude Regulatory News (APTD)

Share Price Information for Aptitude (APTD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 306.00
Bid: 301.00
Ask: 306.00
Change: -3.50 (-1.14%)
Spread: 5.00 (1.661%)
Open: 307.00
High: 307.00
Low: 306.00
Prev. Close: 307.00
APTD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update and Directorate Changes

13 Jul 2023 07:00

RNS Number : 8522F
Aptitude Software Group PLC
13 July 2023
 

13 July 2023

APTITUDE SOFTWARE GROUP PLC

('Aptitude' or the 'Group')

Trading Update, Directorate Changes and Notice of Results

 

Aptitude Software Group plc (LSE: APTD), the specialist provider of Finance Digitalization and Subscription Management software, today provides an update on trading for the six month period ended 30 June 2023 as well as notification of changes to the Board.

 

Trading Update for the six months ended 30 June 2023

The Group will show modest revenue and profit progression to H1 2023 despite the macro economic headwinds faced by the sector and the economy generally. The Board are confident that the Group will meet profit expectations for FY2023.

 

Annual Recurring Revenue ('ARR') grew at an annualised rate of 3% on a constant currency basis to £49.8m at 30 June 2023 (31 December 2022 £50.5m, 30 June 2022: £48.1m - both restated for prevailing exchange rates at 30 June 2023). ARR growth has moderated as the higher levels of churn experienced in 2022 persisted through H1 2023 for Subscription, Billing, and Revenue Management as certain clients monitor spend as a result of wider economic uncertainty and high inflation.

 

Whilst this macro economic backdrop presents a near term challenge for Aptitude's heritage products as sales cycles have lengthened, the Board are confident that the requirement for greater efficiency and effectiveness strengthens the value proposition for Fynapse, which drives a lower cost of ownership for clients while increasing operational productivity. Recognising the economic circumstances, the Board took action in H1 to drive cost efficiencies across the Group whilst protecting investment in areas of strategic focus, including Fynapse.

 

Whilst headline growth in annualised ARR is lower than in previous periods, customer, prospect and partner feedback reinforce the opportunity presented by the Group's two strategic growth drivers of Finance Digitalization and Subscription Management. The Board particularly views the opportunity presented by Fynapse, Aptitude's next-generation fully automated finance management platform that is underpinned by the Group's strategic partnership with Microsoft, as a material accelerator of future growth. The US Telco charter client continues to make strong progress with its implementation. The strengthening pipeline of opportunities for Fynapse, both through Aptitude's strategic partnerships and through traditional avenues, supports growing confidence of future revenue growth.

 

Aptitude remains financially robust, with strong revenue visibility and a closing cash balance at 30 June 2023 of £24.5m (31 December 2022: £29.2m, 30 June 2022: £23.6m) and net funds of £12.2m (31 December 2022: £15.9m, 30 June 2022: £10.7m).

 

Board Changes

The Board announces that Jeremy Suddards, Chief Executive Officer, will be stepping down as Chief Executive Officer. Jeremy joined the Board in September 2019 and became Chief Executive Officer in January 2020. The Board would like to thank Jeremy for his work transitioning the Group from its compliance focus to a leading provider of both Finance Digitalization and Subscription Management software and for his leadership through the COVID pandemic.

Effective immediately, Alex Curran, currently Regional CEO for the Group's North American business, will join the Board and assume the role of Acting Chief Executive Officer whilst the Board conduct a formal search process. Alex joined Aptitude Software in 2008 and she has held several senior roles within the Group including leading the North American business since July 2019. In that time, Alex has overseen strong growth in North America, which now accounts for over half of the Group's recurring revenue.

Commenting on the Board changes, Ivan Martin said:

"The strategic partnership with Microsoft to integrate Fynapse and Dynamics 365 presents a significant global opportunity for the Group. With Alex's strategic sales focus and experience within the North American market, including with key clients and partners, she is well placed to drive the execution of the growing global pipeline.

On behalf of the Board, I would like to thank Jeremy for his work in transitioning the Group and wish him well for the future."

Notice of Results

Aptitude anticipates issuing its Interim Results for the six months ended 30 June 2023 on Wednesday 26 July 2023.

The person responsible for releasing this announcement is Mike Johns, Chief Financial Officer.

Contacts

Aptitude Software Group plc

Ivan Martin, Chairman 020-3687-3200

Mike Johns, Chief Financial Officer

Alex Curran, Acting CEO

Alma PR

Caroline Forde / Hilary Buchanan 020-3405-0205

 

Additional Information Regarding Alex Curran

Alex Curran is a non-executive director of Checkit plc, a company quoted on AIM. No further details are required to be disclosed in respect of Alex's appointment to the Board under LR 9.6.13 of the Listing Rules of the Financial Conduct Authority.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCDLLFFXDLBBBD
Date   Source Headline
25th Feb 20157:02 amRNSReturn of Value
25th Feb 20157:01 amRNSPreliminary Results
28th Jan 20152:02 pmRNSHolding(s) in Company
23rd Jan 20151:17 pmRNSHolding(s) in Company
23rd Jan 20157:00 amRNSTrading Update
21st Jan 201512:14 pmRNSDirector Declaration
5th Jan 20157:00 amRNSBlocklisting Interim Review
5th Dec 20147:00 amRNSAcquisition
3rd Nov 20147:00 amRNSTotal Voting Rights
30th Oct 20147:00 amRNSInterim Management Statement
7th Oct 20142:28 pmRNSAdditional Listing
30th Sep 20142:47 pmRNSBlocklisting Interim Review
15th Sep 20145:04 pmRNSHolding(s) in Company
1st Sep 20147:00 amRNSTotal Voting Rights
21st Jul 20147:00 amRNSInterim Results
14th Jul 20143:00 pmRNSNotice of Results
1st Jul 201412:11 pmRNSBlocklisting Interim Review
20th Jun 20148:10 amRNSDirector Declaration
17th Jun 20147:00 amRNSStatement regarding Elektron Technology plc
11th Jun 20149:34 amPRNForm 8 (OPD) Microgen plc
5th Jun 20142:20 pmRNSForm 8.3 - Microgen Plc
5th Jun 201412:13 pmRNSForm 8.3 - Microgen PLC
2nd Jun 20145:33 pmRNSForm 8 (OPD) Microgen plc
2nd Jun 201412:35 pmRNSForm 8.3 - [Microgen Plc]
2nd Jun 201410:50 amRNSTotal Voting Rights
30th May 201410:23 amBUSForm 8.3 - Microgen Plc
29th May 201410:08 amRNSRule 8.3 opening position disclosure
27th May 20142:39 pmPRNForm 8.3 - Microgen plc
27th May 20142:10 pmRNSStatement re Elektron Technology Plc
27th May 201411:44 amRNSForm 8.3 - Microgen Plc
23rd May 20145:22 pmRNSForm 8.3 - Microgen plc
23rd May 201410:22 amRNSForm 8.3 - Microgen Plc
21st May 20143:29 pmRNSForm 8.3 - [Microgen plc]
21st May 20143:04 pmRNSForm 8.3 - Microgen Plc
21st May 20142:13 pmRNSForm 8.3 - MICROGEN PLC
21st May 20141:10 pmRNSForm 8.3 - Microgen Plc
21st May 201411:48 amBUSForm 8.3 - Microgen Plc
21st May 201411:46 amRNSForm 8.3 - [MICROGEN PLC]
21st May 201411:21 amRNSForm 8.3 - MICROGEN ORD GBP0.05
21st May 20149:00 amRNSResponse to Microgen
20th May 201412:39 pmRNSFurther Statement Re Elektron Technology Plc
20th May 201410:20 amRNSStatement re Elektron Technology
2nd May 201410:48 amRNSDirector/PDMR Shareholding
1st May 201410:28 amRNSTotal Voting Rights
28th Apr 201411:28 amRNSResult of AGM
28th Apr 20147:00 amRNSInterim Management Statement
16th Apr 20145:24 pmRNSDirector Declaration
7th Apr 201411:04 amRNSBlocklisting Interim Review
11th Mar 201411:29 amRNSPosting of Annual Report & AGM
26th Feb 20147:00 amRNSPreliminary Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.